Integrating Genomic Data and AI: A Paradigm Shift for Precision Public Health
GS3GS2
Prof. Samir K. Brahmachari advocates for a unified digital ecosystem linking genomic datasets with AI to revolutionize drug discovery and democratize personalized healthcare in India.
The convergence of Artificial Intelligence (AI) and genomic research represents the next frontier in India’s public health strategy. Prof. Samir K. Brahmachari has recently emphasized the urgent need to break down data silos by integrating India’s vast health and genomic datasets into a unified, interoperable platform. This initiative aims to bridge the gap between academic research, public health infrastructure, and the burgeoning startup ecosystem to accelerate the development of affordable, personalized medical solutions.
Currently, India’s health data remains fragmented across various research institutions, hospitals, and state-run databases. By leveraging AI-driven analytics, this data can be transformed into actionable insights, enabling predictive diagnostics and the rapid discovery of indigenous drugs tailored to the Indian population's unique genetic profile. Such a platform would not only reduce the cost of drug development—which is often prohibitive due to long R&D cycles—but also ensure that medical innovation is inclusive and accessible to the marginalized sections of society.
Continue reading — free with login
JeetoBharat publishes daily UPSC current affairs mapped to the Mains syllabus. Log in to read full articles.
Log in to read full articleNo credit card required. Free registered users get unlimited access.
This article was curated using AI. While we strive for accuracy, please verify critical facts from official sources.